Second round of financing of SAW Instrument with KI Kapital, HTGF and KfW successfully completed
SAW Instruments has completed in early February its second financing round of one million EUR and is aiming to reach break-even in fiscal year 2012. “The funds will be invested in particular in the expansion of sales & marketing activities and extending our product portfolio.” says Managing Director Sabine Bois.
After an extremely positive development of the company in 2010, the management is very pleased that the KfW joined as new investor. “We have worked together very well with KI and the HTGF in the last year and are pleased to have found another strong partner with the KfW to help us achieve our strategic objectives.”
This year SAW Instruments will expand its market presence in Central Europe and make its first steps into the U.S. market. In addition, next to the biosensor sam5 another instrument – the sam5 pro – will be introduced in the second quarter to address besides the research market, additional applications especially within quality assurance. The samX to be launched in September 2011 will provide the customer with unmatched flexibility for sample loading and parallel analyses. “The sam5 pro and the samX represent an important step towards meeting the needs of the pharmaceutical and biotech industries. We believe this product portfolio gives us a strong position in our target markets. ” adds Managing Director Dr. Markus Perpeet.
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Genedata Joins Japanese Research Initiative for Metastatic Biomarkers
SYGNIS signs non-exclusive distribution agreement with Cambridge Bioscience Ltd. for UK and Ireland
Milestone for medical research: New method enables comprehensive identification of omega fatty acids - Researchers at the University of Graz and the University of California, San Diego present an effective method to determine omega positions of lipids in complex biological samples including human tissues and blood
Snapshot measurement of single nanostructure’s circular dichroism
Quick and reliable 3-D imaging of curvilinear nanostructures
The spontaneous and sophisticated side of self-assembly
Heraeus Noblelight Acquires Specialty Light Sources Company in the UK
Ovulation filmed from start to finish for the first time - New findings for fertility research
New blood test detects wide range of cancers - Test proved able to detect and indicate site of dozens of types of cancer with high accuracy
Gardner Denver Medical acquires ILS and Zinsser Analytic
Biotage AB and McMaster University sign joint agreement to develop new chemistry platform